The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer

BACKGROUND: BRCA2-associated breast and ovarian cancers are sensitive to platinum-based chemotherapy. It is unknown whether BRCA2-associated prostate cancer responds favorably to such treatment. METHODS: Retrospective analysis of a single-institution cohort of men with castration-resistant metastati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer
Autores principales: Pomerantz, Mark M., Spisák, Sandor, Jia, Li, Cronin, Angel M., Csabai, Istvan, Ledet, Elisa, Sartor, A. Oliver, Rainville, Irene, O’Connor, Edward, Herbert, Zachary T., Szállási, Zoltan, Oh, William K., Kantoff, Philip W., Garber, Judy E., Schrag, Deborah, Kibel, Adam S., Freedman, Matthew L.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5802871/
https://ncbi.nlm.nih.gov/pubmed/28608931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30808
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares